10-Q: Skyward Specialty Insurance Group Reports Strong Q3 2024 Results Driven by Premium Growth
Quarterly Report
Skyward Specialty Insurance Group reported a net income of $36.7 million for the third quarter of 2024, driven by significant growth in gross written premiums and investment income.
Summary
- Skyward Specialty Insurance Group reported a net income of $36.7 million for the third quarter of 2024, compared to $21.7 million for the same period in 2023.
- The company's net income for the first nine months of 2024 was $104.4 million, a significant increase from $56.7 million in the same period of 2023.
- Gross written premiums increased to $400 million in Q3 2024, up from $355.7 million in Q3 2023, and reached $1.35 billion for the first nine months of 2024, compared to $1.14 billion in the same period of 2023.
- Net earned premiums also saw growth, reaching $269.6 million in Q3 2024 and $763.5 million for the first nine months of 2024.
- Net investment income increased to $19.5 million in Q3 2024 and $59.9 million for the first nine months of 2024, driven by a larger asset base and higher yields.
- The company's combined ratio was 92.2% for Q3 2024 and 90.9% for the first nine months of 2024.
- The company's annualized return on equity was 19.3% for Q3 2024 and 19.1% for the first nine months of 2024.
Sentiment
Score: 8
Explanation: The document presents a positive outlook with strong financial results, significant growth, and an upgraded credit rating. While there are some challenges, the overall tone is optimistic and indicates a healthy business.
Positives
- Skyward Specialty experienced significant growth in gross written premiums across multiple underwriting divisions, including transactional E&S, programs, captives, surety, and global property & agriculture.
- The company's investment portfolio generated higher income due to a larger asset base and increased yields.
- The company's financial strength rating was upgraded to A (Excellent) by A.M. Best with a stable outlook.
- The company's annualized return on equity and tangible equity showed strong performance.
- The company has a new share repurchase program authorizing the repurchase of up to $50 million of its common stock.
Negatives
- The loss ratio for Q3 2024 increased by 2.3 points compared to Q3 2023, primarily due to higher catastrophe losses from Hurricanes Helene and Beryl.
- Net written premiums for Q3 2024 decreased compared to Q3 2023, although this was due to the cancellation of a quota share reinsurance contract in 2023.
- The company experienced a decrease in the fair value of limited partnership investments, impacting net investment income.
Risks
- The company is exposed to potential losses from legal proceedings and claims under insurance policies.
- The company's financial results are subject to fluctuations in interest rates and market conditions.
- The company's reinsurance agreements may not fully protect it from losses.
- The company's estimates and assumptions used in preparing financial statements could differ from actual results.
- The company is subject to risks associated with its investments, including credit risk and market risk.
Future Outlook
Management believes that cash receipts from premiums and proceeds from investment income are sufficient to cover cash outflows in the foreseeable future. The company will continue to strategically purchase reinsurance to protect capital and reduce earnings volatility.
Management Comments
- Management believes that cash receipts from premiums and proceeds from investment income are sufficient to cover cash outflows in the foreseeable future.
- The company strategically purchases reinsurance to enhance its business by protecting capital from severity events and reducing volatility in earnings.
Industry Context
The company operates in the specialty insurance market, focusing on underserved and dislocated markets. The results reflect the company's ability to generate growth in a competitive environment, while maintaining a strong financial position. The upgrade in the A.M. Best rating is a positive signal for the company's financial strength and stability.
Comparison to Industry Standards
- Skyward's combined ratio of 92.2% for Q3 2024 is slightly above the industry average for specialty insurers, which typically aim for a combined ratio below 95%.
- The company's annualized return on equity of 19.3% for Q3 2024 is strong compared to the industry average, indicating efficient use of capital.
- The growth in gross written premiums of 12.5% in Q3 2024 and 19% for the first nine months of 2024 is above average for the specialty insurance sector, suggesting strong market demand for its products.
- Compared to peers like Kinsale Capital Group and RLI Corp, Skyward's growth rate is competitive, though these companies may have different risk profiles and target markets.
- The company's investment portfolio is diversified, with a significant portion in fixed income securities, which is a common strategy for insurance companies to manage risk and generate stable returns. The weighted average credit rating of AAis consistent with industry standards for high-quality investment portfolios.
Legal Proceedings
- The company is involved in various legal actions arising from claims made under insurance policies and contracts.
- The company is also a defendant in various legal actions that relate to bad faith claims, disputes with third parties or that involve alleged errors and omissions.
Related Party Transactions
- The company has a managing general agency agreement with RISCOM, in which it holds a 20% ownership interest.
- The company also has advisory and professional services agreements with various affiliated stockholders and directors.
Stakeholder Impact
- Shareholders will benefit from the company's strong financial performance and share repurchase program.
- Employees will benefit from the company's growth and stability.
- Customers will benefit from the company's ability to provide tailored insurance products and services.
- Reinsurers will benefit from the company's strong financial position and ability to manage risk.
Next Steps
- The company will continue to monitor its reinsurance programs and adjust them as needed.
- The company will execute its share repurchase program.
- The company will continue to focus on growing its business in underserved and dislocated markets.
- The company will continue to manage its investment portfolio to generate stable returns.
Key Dates
| Date | Description |
|---|---|
| August 2006 | The company received $58 million from a debenture offering through Delos Capital Trust. |
| May 2019 | The company issued unsecured subordinated notes with an aggregate principal amount of $20 million. |
| March 29, 2023 | The company entered into an unsecured revolving credit facility with a syndicate of participating banks. |
| March 15, 2024 | The company redeemed the Debentures and paid $1.4 million of accrued interest. |
| August 1, 2024 | A.M. Best upgraded Skyward Specialty's financial strength rating to A (Excellent) from A(Excellent). |
| August 30, 2024 | The company entered into the FHLB Loan with the Federal Home Loan Bank of Dallas. |
| September 6, 2024 | The company redeemed $57 million of the draws on the Revolving Credit Facility. |
| October 2024 | The Board of Directors approved a share repurchase program authorizing the repurchase of up to $50 million of the company's common stock. |
| November 1, 2024 | The registrant had 40,099,931 shares of common stock outstanding. |
| November 7, 2024 | The date of the filing of the quarterly report. |
Keywords
insurance, specialty insurance, financial results, premiums, investment income, underwriting, reinsurance, loss ratio, combined ratio, A.M. Best rating
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.